Pandemic and Biodefense Fund

Who else stands to benefit from a swine flu epidemic? Venture capital firm set to reap rewards on swine fluBy Alexander HaislipApr 24, 2009LOS ANGELES, April 24 (Reuters) - The swine flu outbreak is likely to benefit one of the most prolific and successful venture capital firms in the United States: Kleiner Perkins Caufield & Byers, Thomson Reuters Private Equity Week reported on Friday.